A pilot study of antitumor effect of gallium ethylenediaminetetramethylene phosphonate [Ga(III)-EDTMP] in tumor-bearing rats

Advances in Therapy

Volumn 22, Issue 4, 2005, Pages 297-306

  Su, Mingming ^b   Qiu, Yunping ^b   Jia, Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NONE

Author keywords

Bone metastasis; Ga(III) EDTMP; Gallium ethylenediaminetetramethylene phosphonate; Inhibitory rate; Osteolysis

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; ETHYLENEDIAMINE TETRAKIS(METHYLENEPHOSPHONIC ACID); GALLIUM ETHYLENEDIAMINE N,N,N',N' TETRAKISMETHYLENE PHOSPHONATE; GALLIUM NITRATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE METASTASIS; CALCIUM BLOOD LEVEL; CANCER INVASION; CONTROLLED STUDY; DRUG EFFECT; GROWTH INHIBITION; HISTOPATHOLOGY; HYPERCALCEMIA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OSTEOLYSIS; RAT; TUMOR GROWTH; WALKER CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE DENSITY; CARCINOMA 256, WALKER; CHELATING AGENTS; GALLIUM; MALE; NEOPLASM TRANSPLANTATION; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, WISTAR;

EID: 29344466927     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02850079     Document Type: Article

References (33)

1. Twycross RG, Fairfield S. Pain in far-advanced cancer. Pain. 1982;14:303-310.
2. Nielson OS, Munro AJ, Tannock IF. Bone metastases: pathophysiology and management policy. J Clin Oncol. 1991;9:509-524.
3. Yoneda T. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer. 1998;34:240-245.
4. Dodwell DJ, Howell A. The systemic treatment of bone metastases. In: Rubens RD, Fogelman I, eds. Bone Metastases Diagnosis and Treatment. Dorchester, UK: Dorset Press; 1991:121-122.
5. Mundy GR, Martin TJ. The hypercalcemia of malignancy: pathogenesis and management. Metabolism. 1982;31:1247-1277.
6. Kornev VI, Valyaeva VA. Complex compounds of gallium with some phosphorus-containing complexing agents (in Russian). Koord Khim. 1985;11(3):336-338.
7. 68Ga-labelled skeletal-imaging agents for positron scintigraphy. J Nucl Med. 1976;17:1003-1007.
8. 186Re-HEDP as bone therapeutic radiopharmaceuticals. Int J Rad Appl Instrum B. 1987;14:223-232.
9. Louw WK, Dormehl IC, van Rensburg AJ, et al. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model. Nucl Med Biol. 1996;23:935-940.
10. 105Rh-EDTMP and its bone accumulation. Appl Radiat Iso. 2000;52:211-215.
11. Hart MM, Adamson RH. Antitumor activity and toxicity of salts of inorganic group 3a metals: aluminum, gallium, indium, and thallium. Proc Natl Acad Sci. 1971;68:1623-1626.
12. Adamson RH, Canellos GP, Sieber SM. Studies on the antitumor activity of gallium nitrate (NSC-15200) and other group IIIa metal salts. Cancer Chemother Rep. 1975;9:599-610.
13. Crawford ED, Saiers JH, Baker LH, et al. Gallium nitrate in advanced bladder carcinoma: Southwest Oncology Group study. Urology. 1991;38:355-357.
14. Collery P, Keppler B, Madoulet C, Desoize B. Gallium in cancer treatment. Crit Rev Oncol Hematol. 2002;42:283-296.
15. Rayner DC, Orr FW, Shiu RP. Binding of formyl peptides to Walker 256 carcinosarcoma cells and the chemotactic response of these cells. Cancer Res. 1985;45:2288-2293.
16. Mundy GR, Roodman GD, Bonewald LF, Oreffo ROC, Boyce BF. Assays for bone resorption and bone formation. In: Barnes D, Mather JP, Sato GH, eds. Methods in Enzymology. Peptide Growth Factors, Part C. San Diego, CA: Academic Press; 1991:502-510.
17. Raysarkar BC, Chauhan VPS. A new method for determining microquantities of calcium in biological materials. Anal Biochem. 1967;20:155-166.
18. International Federation of Clinical Chemistry (IFCC). Method for alkaline phosphatase. J Clin Chem Clin Biochem. 1986;21:731-748.
19. Jung A, Bornand J, Mermillod B, Edouard C, Meunier PJ. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. Cancer Res. 1984;44:3007-3011.
20. Amman P, Rizzoli R, Slosman D, Bonjour JP. Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry. J Bone Miner Res. 1992;7:311-317.
21. Kurth AA, Kim SZ, Sedlmeyer I, Bauss F, Shea M. Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat. Bone. 2002;30:300-306.
22. Yamazaki I, Shino A, Shimizu Y, Tsukuda R, Shirakawa Y, Kinoshita M. Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats. Life Sci. 1986;38:951-958.
23. Kostenuik PJ, Orr FW, Suyama K, Singh G. Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats. Cancer Res. 1993;53:5452-5457.
24. Akagi T, Ushinohama K, Kage Y, et al. The growth of S-180 cells was monitored by calculating the tumor volume from caliper measurements. Life Sci. 2003;72:1183-1197.
25. Tayek JA, Istfan NW, Jones CT, et al. Influence of the Walker 256 carcinosarcoma on muscle, tumor, and whole-body protein synthesis and growth rate in the cancer-bearing rat. Cancer Res. 1986;46:5649-5654.
26. Lenhard Jr RE, Woo KB, Abeloff MD. Predictive value of regression rates following chemotherapy of small cell carcinoma of the lung. Cancer Res. 1983;43:3013-3017.
27. Guaitani A, Sabatini M, Coccioli G, et al. An experimental rat model of local bone cancer invasion and its responsiveness to ethane-1-hydroxy-1,1- bis(phosphonate). Cancer Res. 1985;45:2206-2209.
28. Bassani D, Sabatini M, Scanziani E, et al. Bone invasion by Walker 256 carcinosarcoma, line A in young and adult rats: effect of etidronate. Oncology. 1990;47:161.
29. 153Sm-EDTMP on calcium hydroxyl-apatite. Int J Radia Appl Instrum. Part A. Appl Radia Isot. 1998;39:495-499.
30. Bockman RS. Studies on the mechanism of action of gallium nitrate. Semin Oncol. 1991;18(suppl 5):21-25.
31. + ATPase by bone-bound gallium. J Bone Miner Res. 1991;6:S127.
32. McSheehy PMJ, Chambers TJ. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology. 1986;118:824-828.
33. Grey A, Mitnick M, Manolagas SC, et al. Interleukin-6 mediates PTH-induced bone resorption in vivo. J Bone Miner Res. 1997;12:112.